Ƶ takes part in global drug regulatory conference

The Saudi delegation is led by Dr. Hisham bin Saad Al-Jadhey who highlighted the event’s importance in working towards shared goals of safe and effective medicines globally. (SPA)
Short Url
  • Topics on the agenda include regulatory reforms, drug safety, and regulating emerging technologies

RIYADH: Ƶ is participating in a major international pharmaceutical regulation conference in India this week.

The 19th International Conference of Drug Regulatory Authorities is taking place in New Delhi from Oct. 14-18, bringing together drug regulators from around the world to discuss key issues in pharmaceutical oversight.

The event is organized by the Indian government, the Central Drugs Standard Control Organization, and the Indian Ministry of Health and Family Welfare, in collaboration with the World Health Organization, with this year’s theme being “Smart Regulation: Delivering Quality-Assured Pharmaceuticals for All.”

India’s Minister of State for Health and Family Welfare Anupriya Patel opened the conference, which aims to enhance cooperation and exchange experiences among regulatory bodies, and formulate crucial recommendations for drug regulation.

Topics on the agenda include regulatory reforms, drug safety, and regulating emerging technologies.

The Saudi delegation is led by Dr. Hisham bin Saad Al-Jadhey, CEO of the Saudi Food and Drug Authority, who highlighted the event’s importance in working towards shared goals of safe and effective medicines globally.